The Role of Grape Seed Extract in the Treatment of Chemo/Radiotherapy Induced Toxicity: A Systematic Review of Preclinical Studies

Nutrition and Cancer

Volumn 67, Issue 5, 2015, Pages 730-740

  Olaku, Oluwadamilola O ^a,b   Ojukwu, Mary O ^a   Zia, Farah Z ^a   White, Jeffrey D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Kelly Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRAPE SEED EXTRACT; GRAPE SEED PROANTHOCYANIDINS; PROANTHOCYANIDIN;

ANIMAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; MOUSE; PRECLINICAL STUDY; RADIATION INJURIES, EXPERIMENTAL; RAT; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GRAPE SEED EXTRACT; MICE; PROANTHOCYANIDINS; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 84934441530     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2015.1029639     Document Type: Article

References (96)

1. Riboli E and Norat T: Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 78, 559-569, 2003.
2. Rossi M, Negri E, Parpinel M, Lagiou P, Bosetti C, et al.: Proanthocyanidins and the risk of colorectal cancer in Italy. Cancer Causes Control 2, 243-250, 2010.
3. World Cancer Research Fund/American Institute for Cancer Research: Food, Nutrition, Physical Activity and the Prevention of Cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007.
4. Craig WJ and Mangels AR: Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc 109, 1266-1282, 2009.
5. Mittal A, Elmets CA, and Katiyar SK: Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 24, 1379-1388, 2003.
6. Meeran SM, Vaid M, Punathil T, and Katiyar SK: Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 30, 520-5287, 2009.
7. Nandakumar V, Singh T, and Katiyar SK: Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269, 378-387, 2008.
8. Wang CZ, Fishbein A, Aung HH, Mehendale SR, Chang WT, et al.: Polyphenol contents in grape seed extracts correlate with antipica effects in cisplatin-treated rats. J Altern Complement Med 11, 1059-1065, 2005.
9. Curry HL, Parkes SE, Powell JE, and Mann JR: Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer 2, 501-508, 2006.
10. Duncan M and Grant G: Oral and intestinal mucositis-causes and possible treatments. Aliment Pharmacol Ther 18, 853-874, 2003.
11. Vincent DT, Ibrahim YF, Espey MG, and Suzuki YT: The role of antioxidants in the era of cardio-oncology. Cancer Chemother Pharmacol 72, 1157-1168, 2013.
12. Spitz DR, Azzam EI, Li JJ, and Guis D: Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23, 311-322, 2004.
13. Baliga MS, Jagetia GC, Venkatesh P, Reddy R, and Ulloor JN: Radioprotective effect of abana, a polyherbal drug following total body irradiation. Br J Radiol 77, 1027-1035, 2004.
14. Prasad KN, Cole WC, and Haase GM: Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage. Br J Radiol 77, 97-99, 2004.
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche, PC, et al.: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700, 2009.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, and The PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. Open Med 3, e123-e130, 2009.
17. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, et al.: Can animal models of disease reliably inform human studies? PLoS Med 7, e1000245, 2010.
18. El Ammar SM, Said SA, El-Damarawy SL, and Suddek GM: Cardioprotective effect of grape-seed proanthocyanidins on doxorubicin-induced cardiac toxicity in rats. Pharm Biol 51, 339-344, 2013.
19. El Boghdady NA: Antioxidant and antiapoptotic effects of proanthocyanidin and ginkgo biloba extract against doxorubicin-induced cardiac injury in rats. Cell Biochem Funct 31, 344-351, 2012.
20. Mokni M, Hamlaoui-Guesmi S, Amri M, Marzouki L, Limam F, et al.: Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat heart. Cardiovasc Toxicol 12, 158-165, 2012.
21. Ammar EM, Said SA, Suddek GM, and El-Damaraw SL: Assessment of cardiac toxicity of doxorubicin on the rat electrocardiogram and its prevention by drugs. Altex 28, 32, 2011.
22. Li J, Liu H, Ramachandran S, Waypa GB, Yin JJ, et al.: Grape seed proanthocyanidins ameliorate doxorubicin-induced cardiotoxicity. Am J Chin Med 38, 569-584, 2010.
23. Yalcin E, Oruc E, Cavusoglu K, and Yapar K: Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice. J Med Food 13, 917-925, 2010.
24. Bogdanovic G, Andric N, Stanic B, Canadanovic-Brunet J, Spasic M, et al.: The effects of proanthocyanidins on cardiotoxic and antitumour activity of doxorubicin. Eur J Cancer 8(Suppl.), 62-63, 2010.
25. Demirkaya E A, Kesik V, Karslioglu Y, Oztas E, et al.: Cardioprotective roles of aged garlic extract, grape seed proanthocyanidin, and hazelnut on doxorubicin-induced cardiotoxicity. Can J Physiol Pharmacol 87,633-640, 2009.
26. Li W, Xu B, Xu J, and Wu XL: Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Basic and Clinical Pharmacology and Toxicology 104, 192-197, 2009.
27. Du Y and Lou H: Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes. Eur J Pharmacol 4, 96-101, 2008.
28. Zhang XY, Li WG, Wu YJ, and Gao MT: Amelioration of doxorubicininduced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. Journal of Pharmacy and Pharmacology 57, 1043-1051, 2005.
29. Bagchi D, Ray SD, Patel D, and Bagchi M: Protection against drug-and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs Exptl Clin Res 27, 3-15, 2001.
30. Ray SD, Wong V, Rinkovsky A, Bagchi M, Raje RR, et al.: Unique organoprotective properties of a novel IH636 grape seed proanthocyanidin extract on cadmium chloride-induced nephrotoxicity, dimethylnitrosamine (DMN)-induced splenotoxicity and mocap-induced neurotoxicity in mice. Research Communications in Molecular Pathology and Pharmacology 107, 105-128, 2000.
31. Bagchi D, Ray SD, Bagchi M, Preuss HG, and Stohs SJ: Mechanistic pathways of antioxidant cytoprotection by a novel IH636 grape seed proanthocyanidin extract. Indian J Exp Biol 40, 717-726, 2004.
32. Hamlaoui S, Mokni M, Limam N, Carrier A, Limam F, et al.: Grape seed and skin extract protects against acute chemotherapy toxicity induced by doxorubicin in rat red blood cells and plasma. Bangladesh Journal of Pharmacology 7, 54-62, 2012.
33. De Rezende AA, Graf U, Guterres ZD, Kerr WE, and Spano MA: Protective effects of proanthocyanidins of grape (Vitis vinifera L.) seeds on DNA damage induced by Doxorubicin in somatic cells of Drosophila melanogaster. Food Chem Toxicol 47, 1466-1472, 2009.
34. Valls-Belles V, Torres MC, Muniz P, Beltran S, Martinez-Alvarez JR, et al.: Defatted milled grape seed protects adriamycin-treated hepatocytes against oxidative damage. Euro J Nutr 45, 251-258, 2006.
35. Attia SM, Al-Bakheet SA, and Al-Rasheed NM: Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress. Oxid Med Cell Longev 3, 404-413, 2010.
36. Postescu ID, Chereches G, Tatomir C, Daicoviciu D, and Filip GA: Modulation of doxorubicin-induced oxidative stress by a grape (Vitis vinifera L.) seed extract in normal and tumor cells. J Med Food 15, 639-645, 2012.
37. Sayed AAR: Proanthocyanidin protects against cisplatin-induced nephrotoxicity. Phyto Res 23, 1738-1741, 2009.
38. Saad AA, Youssef MI, and El-Shennawy LK: Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: The protective effect of grape seed proanthocyanidin extract. Food Chem Toxicol 47, 1499-1506, 2009.
39. Yousef MI, Saad AA, and El-Shennawy LK: Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol 47, 1176-1183, 2009.
40. Attia SM, Helal GK, Abd-Ellah MF, Mansour AM, and El-Sayed ES: The effects of oral grape seed extract on cisplatin-induced cytogenotoxicity in mice. Saudi Pharmaceutical Journal 16, 161-169, 2008.
41. Wang CZ, Fishbein A, Aung HH, Mehendale SR, Chang WT, et al.: Polyphenol contents in grape-seed extracts correlate with antipica effects in cisplatin-treated rats. J Alternative and Complementary Medicine 11, 1059-1065, 2005.
42. Gulgun M, Karaoglu A, Kesik V, Kurt B, Erdem O, et al.: Effect of proanthocyanidin, arginine and glutamine supplementation on methotrexate-induced gastrointestinal toxicity in rats. Experimental and Clinical Pharmacology 32, 657-661, 2010.
43. Gulgun M, Erdem O, Oztas E, Kesik V, Balamtekin N, et al.: Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress. Exptl Toxicol Path 62, 109-115, 2010.
44. Pinheiro FV, Pimentel VC, De Bona KS, Scola G, Salvador M, et al.: Decrease of adenosine deaminase activity and increase of the lipid peroxidation after acute methotrexate treatment in young rats: protective effects of grape seed extract. Cell Biochem Funct 28, 89-94, 2010.
45. Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, et al.: Role of grape seed extract on methotrexate induced oxidative stress in rat Liver. Am J Chin Med 36, 861-872, 2008.
46. Cheah KY, Bastian S, Acott T, and Howarth G: Grape seed extract: Effects on chemotherapy-induced mucositis and inflammatory bowel disease in rats. Supportive Care in Cancer 17, 905-906, 2009.
47. Cheah KY, Howarth GS, Yazbeck R, Wright TH, Whitford EJ, et al.: Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biology and Therapy 8, 382-390, 2009.
48. Joshi SS, Kuszynski CA, and Bagchi D: The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. Current Pharmaceutical Biotechnology 2, 187-200, 2001.
49. Joshi SS, Kuszynski CA, Benner EJ, Bagchi M, and Bagchi D: Amelioration of the cytotoxic effects of chemotherapeutic agents by grape seed proanthocyanidin extract. Antioxid Redox Signal 1, 563-570, 1999.
50. Alcaraz M, Acevedo C, Castillo J, Benavente-Garcia O, Armero D, et al.: Liposoluble antioxidants provide an effective radioprotective barrier. British Journal of Radiology 82, 605-609, 2009.
51. Gao F, Li BL, Sun D, Huang YC, Ni J, et al.: Protective effects of proanthocyanidin on radiation-induced injury of human-derived cells. Academic Journal of Second Military Medical University 30, 641-644, 2009.
52. Saada HN, Said UZ, Meky NH, and Abd El Azime AS: Grape seed extract Vitis vinifera protects against radiation-induced oxidativedamage and metabolic disorders in rats. Phytother Res 23, 434-438, 2009.
53. Jiang BQ and Chang H: Protective effect of grape seed proanthocyanidin and casein peptide on intestinal mucosal barrier in rats with radiation injury. Chin J Clin Rehab 10, 121-123, 2006.
54. Chang H and Jiang BQ: Protective action of grape seed proanthocyanidins combined with casein on radiation damage of rats. Chin Jo Clin Rehab 9, 210-211, 2005.
55. Cetin A, Kaynar L, Kocyigit I, Hacioglu SK, Saraymen R, et al.: The effect of grape seed extract on radiation-induced oxidative stress in the rat liver. Turkish Journal of Gastroenterology 19, 92-98, 2008.
56. Enginar H, Cemek M, Karaca T, and Unak P: Effect of grape seed extract on lipid peroxidation, antioxidant activity and peripheral blood lymphocytes in rats exposed to x-radiation. Phytother Res 21, 1029-1035, 2007.
57. Liu HZ and Zhong JY: Inhibitory effect of grape procyanidin on the cell apoptosis induced by radiation. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 22, 448-451, 2004.
58. Castillo J, Benavente-Garc-?a O, Lorente J, Alcaraz M, Redondo A, et al.: Antioxidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (Procyanidins) from grape seeds (Vitis vinifera): comparative study versus other phenolic and organic compounds. J Agric Food Chem 48, 1738-1745, 2000.
59. Theodore C, Bayle C, Bernheim A, and Wibault P: Secondary leukemia after advanced bladder cancer with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and radiotherapy. BJU Int 90, 470-471, 2002.
60. Smith RE: Risk for the development of treatment related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjunct Breast and Bowel Project experience. Clin Breast Cancer 4, 273-279, 2003.
61. Mistry AR, Felix CA, Whitmarsh RJ, Mason A, Reiter A, et al.: DNA topoisomerase II therapy related acute promyelocytic leukemia. N Engl J Med 352, 1529-1538, 2005.
62. Craford BA, Spaliviero JA, Simpson JM, and Handelsman DJ: Testing the gonadal regression-cytoprotection hypothesis. Cancer Research 58, 5105-5109, 1998.
63. Habertson J and Downey M: Know your phenolics. Australian Viticulture 10, 98-100, 2006.
64. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, et al.: Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134, 613-617, 2004.
65. Ariga T: The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors 21, 197-201, 2004.
66. Kidd PM: Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 14, 226-246, 2009.
67. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, et al.: Resveratrol scavenges reactive oxygenspecies and effects radical-induced cellular responses. Biochemical and Biophysical Research Communications 309, 1017-1026, 2003.
68. Eng ET, Ye J, Williams D, Phung S, Moore RE, et al.: Suppression of estrogen biosynthesis by procyanidin dimmers in red wine and grape seeds. Cancer Res 63, 8516-8522, 2003.
69. Jo JY, Gonzalez de Mejia E, and Lila MA: Effects of grape cell culture extracts on human topoisomerase II catalytic activity and characterization of active fractions. J Agric Food Chem 53, 2489-2498, 2005.
70. Obrink KJ and Rehbinder C: Animal definition: a necessity for the validity of animal experiments? Laboratory Animals 34, 121-130, 2000.
71. Working Committee for the Biological Characterization of Laboratory Animals/GV-Solas: Guidelines for specification of animals and husbandry methods when reporting the results of animal experiments. Laboratory Animals 19, 106-108, 2005.
72. Alfaro V: Specification of laboratory animal use in scientific articles: current low detail in the journal's instructions for authors and some proposals. Experimental and Clinical Pharmacology 27, 495-502, 2005.
73. Juni P, Altman DG, and Egger M: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 323, 42-46, 2001.
74. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, et al.: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134, 663-694, 2001.
75. Festing MF and Altman DG: Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR Journal 43930, 244-258, 2002.
76. Dell RB, Holleran S, and Ramakrishnan R: Sample size determination. ILAR Journal 43, 207-213, 2002.
77. Berbata V, Luyten D, and Heard K: Emergency medicine animal research: does use of randomization and blinding affect the results? Academic Emergency Medicine 10, 684-687, 2003.
78. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, et al.: Evidence for the efficacy of NXY-059 in experimental focal cerebral ischemia is confounded by study quality. Stroke 39, 2824-2829, 2008.
79. Kilkenny C, Parsons N, Kadyszewski E, Festing MFW, Cuthill IC, et al.: Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PloS ONE 4(11), e7824, 2009. doi:10.1371/journal.pone.0007824
80. Speth PA, van Hoesel QG, and Haanen C. Clinical Pharmacokinet 15, 15-31, 1988.
81. Wouters KA, Kremer LC, Miller TL, Herman EH, and Lipshuttz SC: Protecting against anthracycline induced myocardial damage: A review of the most promising strategies. Br J Haematol 13, 561-578, 2005.
82. Horenstein MS, Vander Heide RS, and L'Ecuyer TJ: Molecular basis of anthracycline induced cardiotoxicity and its prevention. Mol Genet Metab 71, 436-444, 2000.
83. Doroshow JH, Locker GY, and Myers CE: Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 65, 128-135, 1980.
84. Singal PK, Siveski-Iliskovic N, Hill M, Thomas TP, and Li T: Combination therapy with probucol prevents Adriamycin-induced cardiomyopathy. J Mol Cell Cardiol 27, 1055-1063, 1995.
85. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, et al.: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 309, 1017-1026, 2003.
86. Aoshima H, Satoh T, and Sakai N: Generation of free radicals during lipid hydroperoxide-triggered apoptosis in PC12h cells. Biochim Biophys Acta 1345, 35-42, 1997.
87. Lin KT, Xue JY, Nomen M, Spur B, and Wong PY. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 270, 16487-16490, 1995.
88. Zhang B, Su Y, Ai G, Wang Y, Wang T, et al.: Involvement of peroxiredoxin I in protecting cells from radiation-induced death. J Radiat Res 46, 305-312, 2005.
89. Patt HM, Tyree EB, Straube RL, and Smith DE: Cysteine protection against X irradiation. Science 110, 213-214, 1949.
90. Yuhas, JM, Spellman JM, and Culo F: The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials 3, 211-216, 1980.
91. Hooijmans CR, Rovers M, de Vries RB, Leenaars M, and Ritskes-Hoitinga M: An initiative to facilitate well informed decision making in laboratory animal research: report of the first international symposium on systematic reviews in laboratory animal science. Lab Anim 46, 356, 2012.
92. Sena ES, van der Worp HB, Bath PM, Howells DW, and Macleod MR: Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8(3), e1000344, 2010. doi:10.1371/journal. pbio.1000344
93. Clinical Trials.gov: Search for studies 2014. Available from http:clinicaltrials. gov/ct2/results?termD%22grapeCseedCextract%22CANDC%22Cancer. . .
94. Brooker S, Martin S, Pearson A, Bagchi D, Earl J, et al.: Double blind, placebo-controlled randomized phase II tiral of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration. Radiother Oncol 79, 45-51, 2006.
95. Mooiman KD, Maas-Bakker RF, Hendrix JJ, Bank PC, Rosing H, et al.: The effect of complementary and alternative medicines on CYP3A4 mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel. J Pharm Pharmacol 66, 865-874, 2014. doi:10.1111/jphp. 12208
96. Wanwimolruk S,Wong K, and Wanwimolruk P: Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metabol Drug Interact 24, 17-35, 2009.